Back to top
more

Brown & Brown (BRO)

(Delayed Data from NYSE)

$81.54 USD

81.54
1,167,456

+0.08 (0.10%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $81.53 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (36 out of 252)

Industry: Insurance - Brokerage

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Brown & Brown (BRO) Stock Might be a Great Pick

by Zacks Equity Research

Brown & Brown (BRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Arthur J. Gallagher (AJG) Q4 Earnings & Revenues Top, Up Y/Y

by Zacks Equity Research

Arthur J. Gallagher's (AJG) fourth-quarter results reflect higher adjusted revenues and margin expansion across the Brokerage and Risk Management segments.

Marsh & McLennan (MMC) Q4 Earnings Beat on Solid US Business

by Zacks Equity Research

Marsh & McLennan's (MMC) fourth-quarter results benefit from expanding operations across Latin America and EMEA, partly offset by higher operating expenses.

W.R. Berkley's (WRB) Q4 Earnings Beat on Higher Premiums

by Zacks Equity Research

W.R. Berkley's (WRB) Q4 results reflect higher premiums, a rise in the core portfolio, increased underwriting income and an improvement in the loss ratio.

The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson

by Zacks Equity Research

Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Novartis, Amgen & Palo Alto Networks

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo Alto Networks, Inc. (PANW).

Progressive's (PGR) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Progressive's (PGR) fourth-quarter 2023 results reflect year-over-year improvement in the top line.

Brown & Brown's (BRO) Q4 Earnings & Revenues Top Estimates

by Zacks Equity Research

Brown & Brown's (BRO) Q4 results reflect strong organic growth, improved EBITDAC margin and higher net investment income, as well as lower expenses.

Here's What Key Metrics Tell Us About Brown & Brown (BRO) Q4 Earnings

by Zacks Equity Research

Although the revenue and EPS for Brown & Brown (BRO) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Arthur J. Gallagher (AJG) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Insights Into Brown & Brown (BRO) Q4: Wall Street Projections for Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of Brown & Brown (BRO) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance

by Zacks Equity Research

Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.

Marsh & McLennan (MMC) Up 14% in a Year: Upside Potential Left?

by Zacks Equity Research

Growth in the Latin America and Asia regions is expected to buoy Marsh & McLennan's (MMC) results.

Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Investors Should Bet on Brown & Brown (BRO) Now

by Zacks Equity Research

Brown & Brown (BRO) stands to gain from robust new businesses, premium rate increases across the majority of business lines, expansion initiatives, strategic buyouts and a strong financial position.

Arthur J. Gallagher (AJG) Adds Koberich to its Portfolio

by Zacks Equity Research

Arthur J. Gallagher's (AJG) buyout of Koberich is set to help it consolidate its presence in Europe.

Here's Why Hold Strategy is Apt for Willis Towers (WTW) Now

by Zacks Equity Research

Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.

Arthur J Gallagher (AJG) Rises 20% in a Year: More Upside Left?

by Zacks Equity Research

Arthur J Gallagher (AJG) is poised to grow from solid performance of the Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.

Travelers (TRV) Boosts Cyber Capabilities With Corvus Buyout

by Zacks Equity Research

Travelers (TRV) buyout of Corvus Insurance marks its step toward enhancing its cyber capabilities, a part of its strategic growth roadmap.

Here's Why Prudent Investors are Retaining AON Shares Now

by Zacks Equity Research

We expect AON's Reinsurance Solutions and Health Solutions businesses to play significant roles in top-line growth.

Is Bay Commercial Bank (BCML) Stock Outpacing Its Finance Peers This Year?

by Zacks Equity Research

Here is how Bay Commercial Bank (BCML) and Brown & Brown (BRO) have performed compared to their sector so far this year.

Brown & Brown (BRO) Expands in Florida With Caton-Hosey Buyout

by Zacks Equity Research

Brown & Brown (BRO) signs an agreement to acquire Caton-Hosey, boosting its presence in Florida.

AIG Rises 9.6% in Three Months: What Lies Ahead for Investors?

by Zacks Equity Research

American International (AIG) continues to streamline its operations by axing non-core businesses, focusing on core insurance to improve profitability.

Why You Should Add RenaissanceRe (RNR) Stock to Your Portfolio

by Zacks Equity Research

An improvement in the top line led by higher premiums and net investment income poises RenaissanceRe (RNR) well for growth.

Here's Why You Should Add Aflac (AFL) to Your Portfolio

by Zacks Equity Research

Higher net investment income, lower expenses and improved profit levels from the U.S. business aid Aflac (AFL) well for growth.